Home › NDC Lookup › Ingredients › Bisacodyl › 72090-0131-01
BISACODYL 5 mg Tablet, Coated, 300-count — NDC 72090-0131-01 package photo

BISACODYL 5 mg Tablet, Coated, 300-count

by Pioneer Life Sciences, LLC · 300 TABLET, COATED in 1 BOTTLE (72090-131-01)
NDC 72090-0131-01
🏷️ FDA NDC (as labeled) 72090-131-01 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 72090-131-01
Product NDC 72090-131
11-digit billing NDC 72090013101
RxCUI 308753
UNII 10X0709Y6I
UPC 0372090004962
Application # 505G(a)(3)
SPL Set ID 5fdfda7f-76e9-4343-b9fa-03bd2900a851
Established class (EPC) Stimulant Laxative
Physiologic effect Increased Large Intestinal Motility; Stimulation Large Intestine Fluid/Electrolyte Secretion
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-03-02
Route ORAL
Dosage form TABLET, COATED
Substance BISACODYL
Why two NDCs? The FDA registers this code as 72090-131-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72090-0131-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Stimulant Laxative class.

Pharmacologic class Stimulant Laxative
Drug family (ATC) Contact laxatives, Enemas
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerPioneer Life Sciences, LLC
FDA application505G(a)(3) (OTC MONOGRAPH DRUG)
Labeler code72090
First marketedMar 2026
Product typeHuman Otc Drug
Portfolio65 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📖 What it is MedlinePlus · NLM

Bisacodyl is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Bisacodyl is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It depends on which form you're using. Oral tablets (like Dulcolax Stimulant Laxative) usually take 6 to 12 hours, so many people take them at bedtime and get results in the mornin...
  • No — it's really important not to chew, crush, or break bisacodyl tablets. They have a special protective coating that helps them reach the right part of your gut without irritatin...
  • Can I chew or crush the tablet if I have trouble swallowing?
  • Milk and antacids can break down the protective coating on bisacodyl tablets too soon, before the medicine reaches where it needs to work. This can cause stomach irritation and mak...
📖 Read our full Bisacodyl guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color orange
ShapeRound
ImprintO
Size5 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII I753WB2F1M
    FD&C Yellow No. 5 is a synthetic yellow colorant approved by the FDA. It is added to medicines to make pills, tablets, or liquids visually distinct and easier to identify.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 74G4R6TH13
    A synthetic polymer made by combining two plastic-like chemicals. It forms a coating on tablets or capsules that dissolves at a specific point in the digestive tract, controlling where and when the medicine releases.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII H8AV0SQX4D
    A modified starch derived from potato or corn starch. It absorbs water quickly and helps tablets or capsules break apart and dissolve in the stomach, acting as a disintegrant to ensure the medicine releases its active ingredients properly.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII XHX3C3X673
    Triacetin is a clear, oily liquid made from glycerin and acetic acid. It works as a plasticizer and solvent in medicines, helping soften coatings and improve how liquids mix together in formulations.
  • UNII 8Z96QXD6UM
    Triethyl citrate is a clear liquid derived from citric acid. It acts as a plasticizer and solvent in tablet coatings and film formulations, helping the coating remain flexible and adhere properly to the medicine.

13 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesColloidal silicon dioxide, hypromellose, lactose monohydrate, microcrystalline cellulose, magnesium stearate, sodium starch glycolate, talc, opadry clear contain hypromellose, triacetin and talc. Opadry enteric coating orange contain fd&c yellow # 5, fd&c yellow # 6, methacrylic acid copolymer, talc, titanium dioxide, triethyl citrate

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bisacodyl 5 mg 00904-6407-61 Major 10 tablets $0.046 — Availability likely —
Bisacodyl 5 mg 00904-6748-17 Major 25 tablets $0.046 — Availability likely —
Womens Gentle Laxative 5 mg 46122-0429-63 Amerisource 25 tablets $0.046 — Availability likely —
Gentle Laxative 5 mg 46122-0529-63 Amerisource 25 tablets $0.046 — Availability likely —
Gentle Laxative 5 mg 70000-0221-01 Cardinal 10 tablets $0.046 — Availability likely —
Gentle Laxative 5 mg 70000-0538-01 CARDINAL 100 tablets $0.046 — Availability likely —
Laxative 5 mg 70677-1086-01 Strategic 10 tablets $0.046 — Availability likely —
Gentle Laxative 5 mg 83324-0033-30 Chain 15 tablets $0.046 — Availability likely —
Laxative 5 mg 83324-0061-30 Chain 25 tablets $0.046 — Availability likely —
Fleet 5 mg 00132-0401-25 C.B. 25 tablets — — FDA listed —
Gentle Laxative 5 mg 00363-0327-03 Walgreen 10 tablets — — FDA listed —
Laxative 5 mg 00363-6760-01 Walgreen 15 tablets — — FDA listed —
up and up gentle laxative 5 mg 11673-0116-25 Target 25 tablets — — FDA listed —
Womens Gentle Laxative 5 mg 11673-0151-52 TARGET 25 tablets — — FDA listed —
Bisacodyl 5 mg 11673-0182-52 TARGET 25 tablets — — FDA listed —
laxative for women 5 mg 11822-0676-05 Rite 15 tablets — — FDA listed —
Laxative 5 mg 11822-0790-01 Rite 25 tablets — — FDA listed —
Gentle Laxative 5 mg 21130-0410-20 BETTER 200 tablets — — FDA listed —
Womens Gentle Laxative 5 mg 21130-0555-30 BETTER 30 tablets — — FDA listed —
Gentle Overnight Laxative 5 mg 21130-0827-06 Better 200 tablets — — Discontinued —
Laxative Gentle 5 mg 30142-0827-12 Kroger 25 tablets — — FDA listed —
Gentle Laxative 5 mg 36800-0327-03 Topco 10 tablets — — FDA listed —
Gentle Laxative 5 mg 37808-0327-15 H 25 tablets — — FDA listed —
Womens Laxative 5 mg 37808-0676-11 H 15 tablets — — Discontinued —
Gentle Laxative 5 mg 37808-0680-11 H 15 tablets — — FDA listed —
Laxative 5 mg 37835-0241-01 Bi-Mart 100 tablets — — FDA listed —
Gentle Laxative 5 mg 37835-0244-30 Bi-Mart 15 tablets — — FDA listed —
Gentle Laxative 5 mg 41163-0607-52 United 18 tablets — — FDA listed —
Dulcolax Simulant Laxative 5 mg 41167-0101-00 Chattem, 8 tablets — — FDA listed —
Dulcolax Stimulant Laxative 5 mg 41167-0200-01 Chattem, 10 tablets — — FDA listed —
Dulcolax Pink Stimulant Laxative 5 mg 41167-0290-05 Chattem, 25 tablets — — FDA listed —
Dulcolax Stimulant Laxative 5 mg 41167-0400-01 Chattem, 10 tablets — — FDA listed —
Bisacodyl 5 mg 41226-0003-52 KROGER 25 tablets — — FDA listed —
Womens Laxative 5 mg 41226-0151-52 KROGER 25 tablets — — FDA listed —
gentle laxative 5 mg 41250-0339-56 Meijer 25 tablets — — FDA listed —
Womens gentle laxative 5 mg 41250-0676-11 Meijer 15 tablets — — FDA listed —
Publix Stimulant Laxative 5 mg 41415-0116-25 PUBLIX 25 tablets — — FDA listed —
Publix Women Laxative 5 mg 41415-0121-30 PUBLIX 30 tablets — — FDA listed —
Gentle Laxative 5 mg 46122-0767-11 Amerisource 25 tablets — — FDA listed —
Gentle Laxative 5 mg 49035-0327-12 Wal-Mart 100 tablets — — FDA listed —
Gentle Laxative 5 mg 49035-0706-12 Wal-Mart 100 tablets — — FDA listed —
Stimulant Laxative 5 mg 49483-0003-00 TIME 100000 tablets — — FDA listed —
Bisacodyl Laxative 5 mg 50804-0327-56 Geiss, 25 tablets — — FDA listed —
Gentle Laxative 5 mg 50844-0327-15 L.N.K. 25 tablets — — FDA listed —
Womens Gentle Laxative 5 mg 53943-0676-01 Discount 15 tablets — — FDA listed —
Gentle Laxative 5 mg 53943-0677-01 Discount 15 tablets — — FDA listed —
Bisacodyl 5 mg 55154-6897-00 Cardinal 1 tablet — — FDA listed —
Laxative 5 mg 55319-0327-15 Family 25 tablets — — FDA listed —
Gentle Laxative 5 mg 55319-0697-56 Family 25 tablets — — FDA listed —
Laxomil 5 mg 55758-0504-01 Pharmadel 24 tablets — — FDA listed —
Gentle Laxative 5 mg 55910-0327-62 DOLGENCORP, 15 tablets — — FDA listed —
Laxative Gentle 5 mg 55910-0723-62 DOLGENCORP, 15 tablets — — FDA listed —
Laxative 5 mg 55910-0792-56 DOLGENCORP, 25 tablets — — FDA listed —
Extra Gentle Laxative 5 mg 55910-0954-52 DOLGENCORP 25 tablets — — FDA listed —
laxative 5 mg 56062-0327-56 Publix 25 tablets — — FDA listed —
Laxative 5 mg 56062-0976-01 Publix 15 tablets — — FDA listed —
stimulant laxative enteric coated 5 mg 57896-0441-01 Geri-Care 100 tablets — — FDA listed —
Gentle Laxative 5 mg 59779-0327-03 CVS 10 tablets — — FDA listed —
C-Lax Laxative 5 mg 59779-0676-13 CVS 250 tablets — — FDA listed —
Womens Gentle Laxative 5 mg 63868-0573-30 CHAIN 15 tablets — — FDA listed —
Gentle Laxative Stimulant Laxative 5 mg 63868-0908-25 QUALITY 25 tablets — — FDA listed —
Stimulant Laxative Enteric Coated 5 mg 66424-0002-01 SDA 100 tablets — — FDA listed —
Laxative Gentle 5 mg 67091-0215-25 WinCo 25 tablets — — FDA listed —
Laxative Women 5 mg 67091-0286-30 WinCo 15 tablets — — Discontinued —
Laxative 5 mg 67091-0452-24 WinCo 15 tablets — — FDA listed —
Bisacodyl 5 mg 68016-0688-10 Chain 100 tablets — — FDA listed —
Bisacodyl Stimulant Laxative 5 mg 68163-0116-25 Raritan 25 tablets — — FDA listed —
Womens Laxative 5 mg 68998-0398-85 Marc 25 tablets — — FDA listed —
Laxative Enteric Coated 5 mg 68998-0404-92 Marc 25 tablets — — FDA listed —
Bisacodyl 5mg 5 mg 69168-0398-92 Allegiant 25 tablets — — FDA listed —
Laxative Enteric Coated 5 mg 69168-0404-03 Allegiant 250 tablets — — FDA listed —
stimulant laxative 5 mg 69452-0541-83 BIONPHARMA 300 tablets — — FDA listed —
Womens Gentle Laxative 5 mg 69842-0089-52 CVS 25 tablets — — FDA listed —
Womens Laxative Enteric Coated 5 mg 70000-0570-01 CARDINAL 25 tablets — — FDA listed —
GOOD REMEDIES GENTLE Laxative 5 mg 70692-0167-52 Strive 25 tablets — — FDA listed —
RIGHT REMEDIES OVERNIGHT Laxative 5 mg 70692-0761-31 Strive 300 tablets — — FDA listed —
stimulant laxative enteric coated 5 mg 71335-1531-00 Bryant 25 tablets — — FDA listed —
Bisacodyl 5 mg 71335-2010-00 Bryant 25 tablets — — FDA listed —
stimulant laxative enteric coated 5 mg 71610-0453-02 Aphena 2 tablets — — FDA listed —
Bisacodyl 5 mg 71610-0700-02 Aphena 2 tablets — — FDA listed —
Bisacodyl 5 mgthis 72090-0131-01 Pioneer 300 tablets — — FDA listed —
Laxative 5 mg 76162-0676-01 TOPCO 15 tablets — — FDA listed —
SIMPEX Bisacodyl laxative 5 mg 76457-0003-00 Simpex 100 tablets — — FDA listed —
Gentle Laxative 5 mg 79903-0178-08 Wal-Mart 8 tablets — — FDA listed —
Laxative 5 mg 80513-0409-20 Advanced 200 tablets — — FDA listed —
Laxative 5 mg 83586-0116-01 HHH 100 tablets — — FDA listed —
Bisacodyl 5 mg 84324-0132-01 NUVICARE 100 tablets — — FDA listed —
stimulant laxative enteric coated 5 mg 85766-0148-00 Sportpharm 1000 tablets — — FDA listed —
Laxative Enteric Coated 5 mg 85828-0404-92 Grocery 25 tablets — — FDA listed —
HyVee Stimulant Laxative 5 mg 42507-0167-10 HyVee 10 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2026
On the market since
Mar 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
72090-0131-01 You're viewing this 300 TABLET, COATED in 1 BOTTLE (72090-131-01) 2026-03-02 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 72090-131-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 72090-0131-01, written without dashes as 72090013101. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 72090-0131-01, the first segment (72090) is the labeler code FDA assigned to Pioneer Life Sciences, LLC; the middle segment (0131) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Pioneer Life Sciences, LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Pioneer Life Sciences, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 21 words ▾

Use ■ for relief of occasional constipation and irregularity ■ this product generally produces bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 52 words ▾

Directions ■ Take with a glass of water adults and children12 years of age and over start with 1 tablet/day. If needed increase to 2 or 3 tablets a day in a single daily dose. children 6 to under 12 years 1 tablet per day children under 6 years ask a doctor

⚠️ Warnings 11 words ▾

Warnings Do not use ■ if you cannot swallow without chewing

📦 Storage and Handling 12 words ▾

Other information ■ store at 20°-25°C (68°-77°F) ■ protect from excessive humidity

🧪 Active Ingredient 9 words ▾

Active ingredient (in each tablet) Bisacodyl USP 5 mg

🧪 Inactive Ingredients 44 words ▾

Inactive ingredients Colloidal silicon dioxide, hypromellose, lactose monohydrate, microcrystalline cellulose, magnesium stearate, sodium starch glycolate, talc, opadry clear contain hypromellose, triacetin and talc. Opadry enteric coating orange contain fd&c yellow # 5, fd&c yellow # 6, methacrylic acid copolymer, talc, titanium dioxide, triethyl citrate

🎯 Purpose 3 words ▾

Purpose Stimulant laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 72090-0073-01 · PIONEER 72091-0009-00 · PLS →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.